- Home
- PLBC vs NAUT Comparison
PLBC vs NAUT Comparison
Compare PLBC & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLBC | NAUT |
|---|---|---|
| Founded | 1980 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.9M | 305.7M |
| IPO Year | 2002 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PLBC | NAUT |
|---|---|---|
| Price | $50.75 | $2.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $55.50 | $4.00 |
| AVG Volume (30 Days) | 25.1K | ★ 212.8K |
| Earning Date | 04-22-2026 | 05-29-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ 2.94 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.59 | N/A |
| Revenue Next Year | $5.15 | N/A |
| P/E Ratio | $17.26 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.71 | $0.62 |
| 52 Week High | $54.58 | $3.08 |
Technical Indicators
Market Signals| Indicator | PLBC | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 50.19 | 48.77 |
| Support Level | $40.95 | $1.82 |
| Resistance Level | $52.01 | $2.38 |
| Average True Range (ATR) | 1.35 | 0.29 |
| MACD | -0.43 | -0.02 |
| Stochastic Oscillator | 33.42 | 32.52 |
Price Performance
Historical ComparisonAbout PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.